The DOI matches its Crossref record.
The Meningococcal Vaccine Candidate Neisserial Surface Protein A (NspA) Binds to Factor H and Enhances Meningococcal Resistance to Complement
Open accessAbstract
Complement forms an important arm of innate immunity against invasive meningococcal infections. Binding of the alternative complement pathway inhibitor factor H (fH) to fH-binding protein (fHbp) is one mechanism meningococci employ to limit complement activation on the bacterial surface. fHbp is a leading vaccine candidate against group B Neisseria meningitidis. Novel mechanisms that meningococci employ to bind fH could undermine the efficacy of fHbp-based vaccines. We observed that fHbp deletion mutants of some meningococcal strains showed residual fH binding suggesting the presence of a second receptor for fH. Ligand overlay immunoblotting using membrane fractions from one such strain showed that fH bound to a approximately 17 kD protein, identified by MALDI-TOF analysis as Neisserial surface protein A (NspA), a meningococcal vaccine candidate whose function has not been defined. Deleting nspA, in the background of fHbp deletion mutants, abrogated fH binding and mAbs against NspA blocked fH binding, confirming NspA as a fH binding molecule on intact bacteria. NspA expression levels vary among strains and expression correlated with the level of fH binding; over-expressing NspA enhanced fH binding to bacteria. Progressive truncation of the heptose (Hep) I chain of lipooligosaccharide (LOS), or sialylation of lacto-N-neotetraose LOS both increased fH binding to NspA-expressing meningococci, while expression of capsule reduced fH binding to the strains tested. Similar to fHbp, binding of NspA to fH was human-specific and occurred through fH domains 6-7. Consistent with its ability to bind fH, deleting NspA increased C3 deposition and resulted in increased complement-dependent killing. Collectively, these data identify a key complement evasion mechanism with important implications for ongoing efforts to develop meningococcal vaccines that employ fHbp as one of its components.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Complement System Part II: Role in Immunity
Merle, N. S., Noe, R., Halbwachs-Mecarelli, L., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00257 · Cited by 1,051
Serruto, D., Bottomley, M. J., Ram, S., Giuliani, M. M., & Rappuoli, R. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.033 · Cited by 404
Self-citationProperdin and factor h: Opposing players on the alternative complement pathway “see-saw”
Kouser, L., Abdul-Aziz, M., Nayak, A., Stover, C. M., Sim, R. B., & Kishore, U. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00093 · Cited by 91
Hijacking Factor H for Complement Immune Evasion
Moore, S. R., Menon, S. S., Cortes, C., & Ferreira, V. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.602277 · Cited by 83
Lewis, L. A., Gulati, S., Burrowes, E., Zheng, B., Ram, S., & Rice, P. A. (2015) · mBio · doi:10.1128/mbio.02465-14 · Cited by 43
Self-citationStrobel, L., & Johswich, K. O. (2018) · Scientific Reports · doi:10.1038/s41598-018-28583-8 · Cited by 37
Ram, S., Shaughnessy, J., DeOliveira, R. B., Lewis, L. A., Gulati, S., & Rice, P. A. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.05.016 · Cited by 35
Self-citationLucidarme, J., Findlow, J., Chan, H., Feavers, I. M., Gray, S. J., Kaczmarski, E. B., Parkhill, J., Bai, X., Borrow, R., & Bayliss, C. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076932 · Cited by 21
“Other MenB vaccines have not focused on potential redundancy-mediated escape in this way [27,28].”
Background
Metadata
- Authors
- Lewis, L. A., Ngampasutadol, J., Wallace, R., Reid, J. E. A., Vogel, U., & Ram, S.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-07-29
- Volume
- 6
- Issue
- 7
- Pages
- e1001027
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W2018831327
- Cited by
- 159
- References
- 0
- FWCI
- 15.63
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.